Oxford Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?
OXFORD PHARMS has thirty-three approved drugs.
Drugs and US Patents for Oxford Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxford Pharms | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 090020-001 | Oct 19, 2011 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Oxford Pharms | BACLOFEN | baclofen | TABLET;ORAL | 077088-001 | Oct 31, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Oxford Pharms | ALPRAZOLAM | alprazolam | TABLET;ORAL | 078491-002 | Sep 25, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.